219
Views
30
CrossRef citations to date
0
Altmetric
Original Research

Improving antitumor outcomes for palliative intratumoral injection therapy through lecithin– chitosan nanoparticles loading paclitaxel– cholesterol complex

, , , , , , , , , & show all
Pages 689-705 | Published online: 23 Jan 2019

References

  • MüllerJMErasmiHStelznerMZierenUPichlmaierHSurgical therapy of oesophageal carcinomaBr J Surg19907788458572203505
  • AllenAMRabinMSReillyJJMentzerSJUnresectable adenoid cystic carcinoma of the trachea treated with chemoradiationJ Clin Oncol200725345521552318048830
  • BruixJShermanMPractice Guidelines Committee AAftSoLD. Management of hepatocellular carcinomaHepatology20054251208123616250051
  • ShapiroMJManagement of malignant biliary obstruction: nonoperative and palliative techniquesOncology1995964934968719095
  • BakkerRCvan EsRJJRosenbergAJWPIntratumoral injection of radioactive holmium-166 microspheres in recurrent head and neck squamous cell carcinomaNucl Med Commun2018393122128914686
  • MehtaHJBegnaudAPenleyAMTreatment of isolated mediastinal and hilar recurrence of lung cancer with bronchoscopic endobronchial ultrasound guided intratumoral injection of chemotherapy with cisplatinLung Cancer201590354254726477968
  • MehtaHJJantzMAEndobronchial ultrasound-guided intratumoral injection of cisplatin for the treatment of isolated mediastinal recurrence of lung cancerJ Vis Exp2017120
  • LiSYLiQGuanWJEffects of para-toluenesulfonamide intratumoral injection on non-small cell lung carcinoma with severe central airway obstruction: a multi-center, non-randomized, single-arm, open-label trialLung Cancer201698435027393505
  • GimbelMIDelmanKAZagerJSTherapy for unresectable recurrent and in-transit extremity melanomaCancer Control200815322523218596674
  • RamakrishnaiahVPRamkumarJPaiDIntratumoural injection of absolute alcohol in carcinoma of gastroesophageal junction for palliation of dysphagiaEcancermedicalscience2014839524550996
  • ParkSWLeeDHParkYSChungJBKangJKSongSYPercutaneous transhepatic choledochoscopic injection of ethanol with OK-432 mixture for palliation of malignant biliary obstructionGastrointest Endosc200357676977312739557
  • BurrisHAVogelCLCastroDIntratumoral cisplatin/epinephrine-injectable gel as a palliative treatment for accessible solid tumors: a multicenter pilot studyOtolaryngol Head Neck Surg199811844965039560102
  • XieMZhouLHuTYaoMIntratumoral delivery of paclitaxel-loaded poly(lactic-co-glycolic acid) microspheres for Hep-2 laryngeal squamous cell carcinoma xenograftsAnticancer Drugs200718445946617351398
  • DuncanICFouriePAAlbertsASDirect percutaneous intratumoral bleomycin injection for palliative treatment of impending quadriplegiaAm J Neuroradiol20042561121112315205162
  • ZhaoLZhuLLiuFpH triggered injectable amphiphilic hydrogel containing doxorubicin and paclitaxelInt J Pharm20114101–2839121421032
  • BragtaPSidhuRKJyotiKIntratumoral administration of carboplatin bearing poly (ε-caprolactone) nanoparticles amalgamated with in situ gel tendered augmented drug delivery, cytotoxicity, and apoptosis in melanoma tumorColloids Surf B Biointerfaces201816633934829627747
  • JiangYMengXWuZQiXModified chitosan thermosensitive hydrogel enables sustained and efficient anti-tumor therapy via intratumoral injectionCarbohydr Polym201614424525327083815
  • Al-AbdAMHongKYSongSCKuhHJPharmacokinetics of doxorubicin after intratumoral injection using a thermosensitive hydrogel in tumor-bearing miceJ Control Release2010142110110719819274
  • LinWYTsaiSCHsiehJFWangSJEffects of 90Y-microspheres on liver tumors: comparison of intratumoral injection method and intra-arterial injection methodJ Nucl Med200041111892189711079501
  • ChangGLiCLuWDingJN-Boc-histidine-capped PLGA-PEG-PLGA as a smart polymer for drug delivery sensitive to tumor extracellular pHMacromol Biosci201010101248125620593367
  • XuXChenXWangZJingXUltrafine PEG-PLA fibers loaded with both paclitaxel and doxorubicin hydrochloride and their in vitro cytotoxicityEur J Pharm Biopharm2009721182519027067
  • GreishKEnhanced permeability and retention (EPR) effect for anticancer nanomedicine drug targetingMethods Mol Biol2010624253720217587
  • WuXLandfesterKMusyanovychAGuyRHDisposition of charged nanoparticles after their topical application to the skinSkin Pharmacol Physiol201023311712320051712
  • TanQLiuWGuoCZhaiGPreparation and evaluation of quercetin-loaded lecithin-chitosan nanoparticles for topical deliveryInt J Nanomed2011616211630
  • SonvicoFCagnaniARossiAFormation of self-organized nanoparticles by lecithin/chitosan ionic interactionInt J Pharm20063241677316973314
  • Wike-HooleyJLHavemanJReinholdHSThe relevance of tumour pH to the treatment of malignant diseaseRadiother Oncol1984243433666097949
  • NamJPParkSCKimTHEncapsulation of paclitaxel into lauric acid-O-carboxymethyl chitosan-transferrin micelles for hydrophobic drug delivery and site-specific targeted deliveryInt J Pharm2013457112413524076228
  • PanZGaoYHengLAmphiphilic N-(2,3-dihydroxypropyl)-chitosan-cholic acid micelles for paclitaxel deliveryCarbohydr Polym201394139439923544554
  • RowinskyEKDonehowerRCPaclitaxel (Taxol)N Engl J Med199533215100410147885406
  • XuJMaLLiuYXuFNieJMaGDesign and characterization of antitumor drug paclitaxel-loaded chitosan nanoparticles by W/O emulsionsInt J Biol Macromol201250243844322230611
  • TaoYXuJChenMBaiHLiuXCore cross-linked hyaluronan-styrylpyridinium micelles as a novel carrier for paclitaxelCarbohydrate Polym2012881118124
  • SparreboomAScriptureCDTrieuVComparative preclinical and clinical pharmacokinetics of a cremophor-free, nanoparticle albumin-bound paclitaxel (ABI-007) and paclitaxel formulated in Cremophor (Taxol)Clin Cancer Res200511114136414315930349
  • XiaXJGuoRFLiuYLFormulation, characterization and hypersensitivity evaluation of an intravenous emulsion loaded with a paclitaxel-cholesterol complexChem Pharm Bull201159332132621372412
  • LiuYLiuLZhouCXiaXSelf-assembled lecithin/chitosan nanoparticles for oral insulin delivery: preparation and functional evaluationInt J Nanomedicine20161176176926966360
  • SinghBMehtaGKumarRBhatiaAAhujaNKatareOPDesign, development and optimization of nimesulide-loaded liposomal systems for topical applicationCurr Drug Deliv20052214315316305415
  • LvQYuAXiYDevelopment and evaluation of penciclovir-loaded solid lipid nanoparticles for topical deliveryInt J Pharm20093721–219119819429280
  • HuhKMLeeSCChoYWLeeJJeongJHParkKHydrotropic polymer micelle system for delivery of paclitaxelJ Control Release20051011–3596815588894
  • JinMJinGKangLChenLGaoZHuangWSmart polymeric nanoparticles with pH-responsive and PEG-detachable properties for co-delivering paclitaxel and survivin siRNA to enhance antitumor outcomesInt J Nanomedicine2018132405242629719390
  • StevensPJSekidoMLeeRJA folate receptor-targeted lipid nanoparticle formulation for a lipophilic paclitaxel prodrugPharm Res200421122153215715648245
  • YeJLiuYXiaXImproved safety and efficacy of a lipid emulsion loaded with a paclitaxel-cholesterol complex for the treatment of breast tumorsOncol Rep201636139940927175803
  • SenyiğitTSonvicoFBarbieriSOzerOSantiPColomboPLecithin/chitosan nanoparticles of clobetasol-17-propionate capable of accumulation in pig skinJ Control Release2010142336837319932722
  • FakhryASchneiderGBZahariasRŞenelSChitosan supports the initial attachment and spreading of osteoblasts preferentially over fibroblastsBiomaterials200425112075207914741622
  • WeiszhárZCzúczJRévészCRosivallLSzebeniJRozsnyayZComplement activation by polyethoxylated pharmaceutical surfactants: Cremophor-EL, Tween-80 and Tween-20Eur J Pharm Sci201245449249821963457
  • WitzIPLevy-NissenbaumOThe tumor microenvironment in the post-PAGET eraCancer Lett2006242111016413116
  • WeberCEKuoPCThe tumor microenvironmentSurg Oncol201221317217721963199
  • KhalilIAKogureKAkitaHHarashimaHUptake pathways and subsequent intracellular trafficking in nonviral gene deliveryPharmacol Rev2006581324516507881
  • WangLHRothbergKGAndersonRGMis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formationJ Cell Biol19931235110711178245121
  • LiuJShapiroJIEndocytosis and signal transduction: basic science updateBiol Res Nurs20035211712814531216
  • LamazeCSchmidSLThe emergence of clathrin-independent pinocytic pathwaysCurr Opin Cell Biol1995745735807495578
  • NamHYKwonSMChungHCellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticlesJ Control Release2009135325926719331853
  • ChiuYLHoYCChenYMThe characteristics, cellular uptake and intracellular trafficking of nanoparticles made of hydrophobically-modified chitosanJ Control Release2010146115215920580915
  • MengHYangSLiZAspect ratio determines the quantity of mesoporous silica nanoparticle uptake by a small GTPase-dependent macropinocytosis mechanismACS Nano2011564434444721563770
  • ManuntaMTanPHSagooPKashefiKGeorgeAJGene delivery by dendrimers operates via a cholesterol dependent pathwayNucleic Acids Res20043292730273915148360
  • JiangSRheeSWGleesonPAStorrieBCapacity of the Golgi apparatus for cargo transport prior to complete assemblyMol Biol Cell20061794105411716837554
  • TrielliMOAndreassenPRLacroixFBMargolisRLDifferential Taxol-dependent arrest of transformed and nontransformed cells in the G1 phase of the cell cycle, and specific-related mortality of transformed cellsJ Cell Biol199613536897008909543
  • RichardIThibaultMde CrescenzoGBuschmannMDLavertuMIonization behavior of chitosan and chitosan–DNA polyplexes indicate that chitosan has a similar capability to induce a proton-sponge effect as PEIBiomacromolecules20131461732174023675916
  • CaoNChengDZouSAiHGaoJShuaiXThe synergistic effect of hierarchical assemblies of siRNA and chemotherapeutic drugs co-delivered into hepatic cancer cellsBiomaterials20113282222223221186059
  • KaurPNagarajaGMZhengHA mouse model for triple-negative breast cancer tumor-initiating cells (TNBC-TICs) exhibits similar aggressive phenotype to the human diseaseBMC Cancer201212112022452810
  • SubramanianAManigandanASivashankariPRSethuramanSDevelopment of nanotheranostics against metastatic breast cancer – a focus on the biology & mechanistic approachesBiotechnol Adv20153381897191126454168